Publications by authors named "Dave Carter"

Claim this Profile
A
Automatic Annotation of Disposition Counts in News Articles.
Simon Rodier, Dave Carter

Stud Health Technol Inform· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results.
Giovanni Scambia, Ricardo Villalobos Valencia, Nicoletta Colombo, David Cibula, Charles A Leath, Dave Carter

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering of extracellular vesicles for efficient intracellular delivery of multimodal therapeutics including genome editors.
Xiuming Liang, Dhanu Gupta, Junhua Xie, Elien Van Wonterghem, Lien Van Hoecke, Dave Carter

Nat Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Public Health Surveillance Using Media Reports: Redesigning GPHIN.
Dave Carter, Marta Stojanovic, Philip Hachey, Kevin Fournier, Simon Rodier

Stud Health Technol Inform· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Essentials of extracellular vesicles: posters on basic and clinical aspects of extracellular vesicles.
Rienk Nieuwland, Juan Manuel Falcon-Perez, Carolina Soekmadji, Eric Boilard, Dave Carter

J Extracell Vesicles· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technical challenges of working with extracellular vesicles.
Marcel I Ramirez, Maria G Amorim, Catarina Gadelha, Ivana Milic, Joshua A Welsh, Dave Carter

Nanoscale· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real Threat or False Alarm: Aare You Prepared for the Next Time the Fire Alarm Sounds?
Dave Carter

Occup Health Saf· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
It Will Never Happen to Us.
Dave Carter

Occup Health Saf· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC).
Ana M Molina, Thomas E Hutson, James Larkin, Anne M Gold, Karen Wood, Dave Carter

Cancer Chemother Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A meta-analysis of the relative doses of erythropoiesis-stimulating agents in patients undergoing dialysis.
Xavier Bonafont, Andreas Bock, Dave Carter, Reinhard Brunkhorst, Fernando Carrera

NDT Plus· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet.
Martin Wilkie, Giuseppe Pontoriero, Fernando Macário, Magdi Yaqoob, Koen Bouman, Dave Carter

Nephron Clin Pract· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ecological future of the North American bison: conceiving long-term, large-scale conservation of wildlife.
Eric W Sanderson, Kent H Redford, Bill Weber, Keith Aune, Dick Baldes, Dave Carter

Conserv Biol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism.
Piergiorgio Messa, Fernando Macário, Magdi Yaqoob, Koen Bouman, Johann Braun, Dave Carter

Clin J Am Soc Nephrol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis